KRTL once the market finds us its off to dollars $KRTL Patricia Wilstermann: A Trailblazing Leader Transforming Bolivia’s Pharmaceutical Industry
https://www.otcmarkets.com/stock/KRTL/news/Pa...?id=495302
KRTL Holding Group Inc. (OTC: KRTL) announced today that Lic. Patricia Wilstermann, CEO of Industria Químico-Farmacéutica SIGMA Corp. S.R.L. (SIGMA), was formally recognized yesterday as one of Bolivia’s top business leaders and a national model for female entrepreneurship in the country’s industrial sector by CIFABOL (Cámara de la Industria Farmacéutica Boliviana).
With more than 50 years of uninterrupted contribution to the pharmaceutical field, Patricia Wilstermann has demonstrated steadfast commitment to advancing Bolivia’s national industry and improving the health and wellbeing of its people. A Licensed Auditor by profession, she has led SIGMA. to become a benchmark in pharmaceutical innovation, ensuring operations meet strict European standards and establishing SIGMA as a leading example of modern Bolivian enterprise.
“God sends each person into this world with a mission, and mine is to work for people — to dedicate myself to healing through service.”— Patricia Wilstermann, CEO, SIGMA.
Under her leadership, SIGMA has designed and constructed one of the most technologically advanced pharmaceutical plants in Bolivia. The facility, located in Cochabamba, was developed in accordance with European regulatory frameworks and is engineered to uphold rigorous international standards of quality, safety, and operational efficiency.
Patricia Wilstermann’s leadership story is one of purpose-driven progress, marked by resilience and a deep sense of social responsibility. In her own words:
“To lead a company, one is not born, one becomes.”— Patricia Wilstermann
She encourages the next generation of female professionals to embrace the values of integrity, commitment, and leadership, especially in traditionally male-dominated sectors such as science, industry, and technology.
“We must be examples for the next generations — examples of energy, strength, commitment, and responsibility.”— Patricia Wilstermann
This recognition underscores both her personal achievements and her ongoing impact on Bolivian industry. Her leadership has not only helped SIGMA thrive in a competitive pharmaceutical market but has also positioned the company to contribute to international health and wellness efforts in partnership with KRTL Biotech, Inc. and KRTL Holding Group Inc.
"Patricia’s achievements as a business leader and healthcare advocate are foundational to our work at KRTL Biotech," said Daniel Bishop, CEO of KRTL Biotech, Inc. "Her dedication to service and community inspires how we operate and expand as an international company."
"We are honored to collaborate with Patricia and SIGMA," said Cesar Herrera, CEO of KRTL Holding Group Inc. "Her leadership exemplifies what it means to combine vision with impact — not just in Bolivia, but across the region and the world."
https://www.otcmarkets.com/stock/KRTL/news/Pa...?id=495302
KRTL Holding Group Inc. (OTC: KRTL) announced today that Lic. Patricia Wilstermann, CEO of Industria Químico-Farmacéutica SIGMA Corp. S.R.L. (SIGMA), was formally recognized yesterday as one of Bolivia’s top business leaders and a national model for female entrepreneurship in the country’s industrial sector by CIFABOL (Cámara de la Industria Farmacéutica Boliviana).
With more than 50 years of uninterrupted contribution to the pharmaceutical field, Patricia Wilstermann has demonstrated steadfast commitment to advancing Bolivia’s national industry and improving the health and wellbeing of its people. A Licensed Auditor by profession, she has led SIGMA. to become a benchmark in pharmaceutical innovation, ensuring operations meet strict European standards and establishing SIGMA as a leading example of modern Bolivian enterprise.
“God sends each person into this world with a mission, and mine is to work for people — to dedicate myself to healing through service.”— Patricia Wilstermann, CEO, SIGMA.
Under her leadership, SIGMA has designed and constructed one of the most technologically advanced pharmaceutical plants in Bolivia. The facility, located in Cochabamba, was developed in accordance with European regulatory frameworks and is engineered to uphold rigorous international standards of quality, safety, and operational efficiency.
Patricia Wilstermann’s leadership story is one of purpose-driven progress, marked by resilience and a deep sense of social responsibility. In her own words:
“To lead a company, one is not born, one becomes.”— Patricia Wilstermann
She encourages the next generation of female professionals to embrace the values of integrity, commitment, and leadership, especially in traditionally male-dominated sectors such as science, industry, and technology.
“We must be examples for the next generations — examples of energy, strength, commitment, and responsibility.”— Patricia Wilstermann
This recognition underscores both her personal achievements and her ongoing impact on Bolivian industry. Her leadership has not only helped SIGMA thrive in a competitive pharmaceutical market but has also positioned the company to contribute to international health and wellness efforts in partnership with KRTL Biotech, Inc. and KRTL Holding Group Inc.
"Patricia’s achievements as a business leader and healthcare advocate are foundational to our work at KRTL Biotech," said Daniel Bishop, CEO of KRTL Biotech, Inc. "Her dedication to service and community inspires how we operate and expand as an international company."
"We are honored to collaborate with Patricia and SIGMA," said Cesar Herrera, CEO of KRTL Holding Group Inc. "Her leadership exemplifies what it means to combine vision with impact — not just in Bolivia, but across the region and the world."
